Arrowhead Pharmaceuticals
ARWR
#2279
Rank
A$11.90 B
Marketcap
A$84.31
Share price
1.22%
Change (1 day)
37.49%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2023 (TTM): A-$2.59

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$4.83. In 2022 the company made an earnings per share (EPS) of A-$2.12 an increase over its 2021 EPS that were of A-$2.55.

EPS history for Arrowhead Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A-$2.5922.19%
2022A-$2.12-17.05%
2021A-$2.5574.26%
2020A-$1.46-283.64%
2019A$0.80-257.14%
2018A-$0.51-27.08%
2017A-$0.70-59.32%
2016A-$1.71-21.85%
2015A-$2.199.42%
2014A-$2.002.87%
2013A-$1.94-31.56%
2012A-$2.84300%
2011A-$0.71-45.56%
2010A-$1.30-66.67%
2009A-$3.91-63.51%
2008A-$10.73-12.94%
2007A-$12.3244.07%
2006A-$8.5577.35%
2005A-$4.8210.66%
2004A-$4.36-54.25%
2003A-$9.53-80.51%
2002A-$48.883.87%
2001A-$47.06116.17%
2000A-$21.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.69-300.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
A-$11.58 139.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$14.51-400.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$28.72-694.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
A-$2.65-45.05%๐Ÿ‡บ๐Ÿ‡ธ USA